Strickland Metals Limited (ASX:STK) Announces High Gold Recovery at Horse Well Gold Camp
Strickland Metals Limited (ASX:STK) reports up to 88.6% gold recovery at Horse Well Gold Camp, strengthening the Yandal Project’s growth prospects.
Tag: Corporate Strategy & Guidance
Top End Energy Limited (ASX:TEE) Selects First Well Site for Serpentine Project
Top End Energy (ASX:TEE) selects first well site for its Serpentine Natural Hydrogen Project, advancing operations in Kansas, USA.
Capricorn Metals Ltd (ASX:CMM) Acquires Kings Find Project
Capricorn Metals Ltd (ASX:CMM) acquires the Kings Find Project for $1.5M, expanding its Mt Gibson portfolio with significant exploration potential.
Proteomics International Laboratories Ltd (ASX:PIQ) Launches Promarker®D Test to Combat Diabetic Kidney Disease in Australia
Proteomics International (ASX:PIQ) launches PromarkerD, a predictive test for diabetic kidney disease, enhancing early diagnosis and intervention.
Boss Energy Limited (ASX:BOE) Increases Stake in Laramide Resources to 18.4%
Boss Energy Limited (ASX:BOE) acquires additional shares in Laramide Resources, increasing its stake to 18.4% and strengthening its position in the uranium sector.
GreenTech Metals Limited (ASX:GRE) Announces Successful Drilling at Whundo Copper Project
GreenTech Metals (ASX:GRE) completes successful drilling at Whundo Copper Project, confirming significant sulphide intersections and promising resource expansion.
Sarytogan Graphite Limited (ASX:SGA) Advances Water Drilling for Kazakhstan Project
Sarytogan Graphite (ASX:SGA) advances water drilling efforts in Kazakhstan to secure essential water supply for its graphite project.
Global Uranium and Enrichment (ASX:GUE) Announces Pine Ridge Acquisition and Equity Raise
Global Uranium and Enrichment (ASX:GUE) secures Pine Ridge Uranium Project through joint venture with Snow Lake Energy and initiates a A$9M equity raise to fund the acquisition and support growth.
Telix Pharmaceuticals Limited (ASX:TLX) Completes Acquisition of FAP-targeting Theranostic Candidates
Telix Pharmaceuticals (ASX:TLX) completes acquisition of FAP-targeting theranostic candidates, expanding its oncology pipeline.
Orica (ASX:ORI) Announces $400 Million On-Market Share Buy-Back
Orica (ASX:ORI) announces a $400 million on-market share buy-back, reflecting confidence in its financial strength and capital management strategy.